Rapid method for the detection of anti-HCV antibodies in patients with chronic hepatitis C

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 3, 2000, Pages 144-146

  Buti, María ^a   Cotrina, M ^a   Chan, H ^a   Jardi R ^b   Rodriguez F ^a   Costa, X ^a   Esteban, R ^a   Guardia J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b MedMira Laboratories   (Canada)

Author keywords

Anti HCV antibodies; Hepatitis C; Rapid method

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS DNA;

ARTICLE; CHEMOLUMINESCENCE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOLOGY; METHODOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME;

CHEMILUMINESCENT MEASUREMENTS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0034152432     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M. Hepatitis C virus: the major causative agent of viral non-A non-B hepatitis. Br Med Bull 1990;46:423-41.
2. Alter H. To C or not to C: These are the questions. J Am Soc Haematol 1996;85:1681-95.
3. McMenamin J. Hepatitis C virus: prevalence and treatment. ANSWER AM-5 WR 1994;94:3-4.
4. Damen M, Zaaijer HL, Cuypers HTM, Vrielink H, van der Poel CL, Reesink HW, et al. Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus. Transfusion 1995;35:745-9.
5. Tibbs C, Palmer S, Coker R, Clark S, Parson G, Hojvat S, et al. Prevalence of hepatitis C in tropical comunities: the importance of confirmatory assays. J Med Virol 1991;34: 143-7.
6. Chien D, Choo QL, et al. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric poly-protein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci 1992;89: 10.011-5.
7. Summers M, et al. Luminogenic reagent using 3-Chloro 4-Hydroxy cetilanide to enhace peroxodase/luminol chemiluminiscence. Clin Chem 1995;41:S73.
8. Viazov S, Zibert A, Ramakrishnan A, Widell A, Cavicchini A, Schreier E, et al. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. Virol Methods 1994;48:81-92.
9. Panteleeff DD, John G, Nduati R, Mbori-Ngacha D, Richrdson B, Kreiss J, et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999;2:350-3.
10. Merryweather-Clarke AT, Liu YT, Shearmen JD, Pointon JJ, Robson KJH. A rapid non-invasive method for the detection of the haemochromatosis C282Y mutation. Br J Haematology 1997;99:460-3.
11. Allander T, Medin C, Kacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-9.
12. Allander T, Gruber A, Nafhavi M, Beyene A, Söderström T, Björkholm M, et al. Frequent patient-to patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-7.
13. Prati D, Capelli C, Silvani C, De Matei C, Bosoni P, Pappalettera M, et al. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997;25:702-4.